Posted on 1/9/18
CardioFocus Announces Expanded Partnership With Japan Lifeline
CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that it has . . .
Posted on 1/9/18
Todd & Weld Expands, Adding Four Accomplished Trial Lawyers
BOSTON--(BUSINESS WIRE)--Four highly accomplished trial attorneys have joined Boston law firm Todd & Weld LLP as partners, significantly expanding its capabilities in white-collar defense, government investigations, . . .
Posted on 1/9/18
Four Geospatial Traceability and Analytics Technology Providers Named IDC Innovators
FRAMINGHAM, Mass.--(BUSINESS WIRE)--International Data Corporation (IDC) today published an IDC Innovators report focusing on four technology vendors that have built tools to address geospatial traceability and . . .
Posted on 1/9/18
Watermill Adds Tracy Streckenbach as Partner
LEXINGTON, Mass.--(BUSINESS WIRE)--The Watermill Group, a strategy-driven private investment firm, today announced the addition of Tracy Streckenbach, a leader in performance improvement, to its team as . . .
Posted on 1/9/18
Kyruus Joins the Epic App Orchard with Direct Scheduling Solution
BOSTON--(BUSINESS WIRE)--Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that it has joined the Epic App Orchard to enable seamless . . .
Posted on 1/9/18
OnProcess Technology Named 2017 Top 10 Healthcare Supply Chain Management Provider
ASHLAND, Mass.--(BUSINESS WIRE)--OnProcess Technology, a global pioneer in service supply chain management and optimization, has been named Healthcare Tech Outlook’s “2017 Top 10 Healthcare Supply Chain . . .
Posted on 1/16/18
Virtusa Wins 2017 North American and Asia-Pacific CandE Awards
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Virtusa Corporation (NASDAQ GS: VRTU), a global business consulting and IT outsourcing company that accelerates business outcomes for its clients, today announced it is . . .
Posted on 1/16/18
Nucleus Research Opens Submissions for 16th Annual ROI Awards
BOSTON--(BUSINESS WIRE)--Nucleus Research has opened submissions for the 2018 Technology ROI Awards at www.ROIAwards.com.“Technology decisions are too critical to business to rely on magic quadrants and . . .
Posted on 1/9/18
Hobbs Brook Management Welcomes Pannone Lopes Devereaux & O’Gara
Leading law firm leased 20,620 RSF at Rhode Island office park Photos courtesy of Pannone Lopes Devereaux & O'Gara LLC Hobbs Brook Management LLC, a commercial . . .
Posted on 1/9/18
GZA Appoints Darin Goodwin as Senior Project Manager
GZA, a multi-disciplinary firm providing environmental, geotechnical, ecological, water and construction management
Posted on 1/9/18
Boston Beer Co.: A Tough Spot
Boston Beer Co. (SAM) is breaking my heart these days. The company is increasingly under pressure to grow, while the very market it created is preventing . . .
Posted on 1/9/18
Strategic Spaces Opens New Headquarters And Showroom In Boston
Chooses Vantage Builders to Renovate Space at 280 Summer St. in Seaport DistrictVantage Builders, Inc., a general contracting and construction firm based in Waltham, Mass., today . . .
Posted on 1/9/18
Skyword Raises $25 Million
Skyword, the leading content marketing software and services company, announced today that it has raised $25 million in growth equity from Rho Acceleration
Posted on 1/9/18
Warren Buffett Invested in This 3D Printing Trend. Should You?
When Warren Buffett pulls the trigger on a major acquisition, he likes to refer to it as "breaking out the elephant gun." But some elephants are . . .
Posted on 1/9/18
Warren Buffett Just Won a 10-Year Million-Dollar Bet: Here's Why
Superinvestor Warren Buffett has recommended never betting against America, noting in his 2015 letter to shareholders: "For 240 years it's been a terrible mistake to bet . . .
Posted on 1/9/18
General Electric's New Avenue For Growth
GE Healthcare is a major operating segment of General Electric (GE). With revenue of $18.29 billion in 2016, it’s one of the company’s largest operations. But . . .
Posted on 1/9/18
SV Health Investors Promotes Michael Balmuth to MD and Houman Ashrafian to Partner
BOSTON and LONDON, Jan. 08, 2018 (GLOBE NEWSWIRE) — SV Health Investors, the venture capital and growth equity firm, has promoted Michael Balmuth to Managing Partner . . .
Posted on 1/9/18
Battery Ventures Leads $58M Series D for Collibra
NEW YORK, Jan. 08, 2018 (GLOBE NEWSWIRE) -- Collibra, leader in enterprise data governance and catalog software, today announced it has closed $58 million in Series . . .
Posted on 1/9/18
Acorda Therapeutics Explores Sale
Acorda Therapeutics Inc, a biotech company, is exploring a potential sale, the Wall Street Journal reported. It has hired investment banks Centerview Partners and MTS Health . . .
Posted on 1/9/18
General Catalyst Fund IX Targets $1B
General Catalyst Partners is seeking $1 billion for its largest fund ever, the Wall Street Journal reported. Fund IX will combine several strategies under one roof, . . .
Posted on 1/9/18
Dunkin' Brands Promotes Scott Murphy To COO
In support of its mission to eventually have 18,000 Dunkin' Donuts restaurants in the U.S., Dunkin' Brands Group, Inc., (Nasdaq: DNKN), the parent company of Dunkin' . . .
Posted on 1/9/18
SolidEnergy Raises $34M Series C
WOBURN, Mass.--(BUSINESS WIRE)--SolidEnergy Systems announced today that it has completed a $34M Series C funding round, bringing the total funding to date to more than $50M.SolidEnergy . . .
Posted on 1/9/18
HFF Announces $250M Construction Financing for First Phase of Bulfinch Crossing Development
BOSTON--(BUSINESS WIRE)--Holliday Fenoglio Fowler, L.P. (HFF) announces the $250 million construction loan for the development of Phase I at Bulfinch Crossing, a 46-story luxury residential tower . . .
Posted on 1/9/18
bluebird bio Closes Over-Allotment Option in Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for . . .
Posted on 1/9/18
Incyte and Syros Announce Global Target Discovery and Validation Collaboration
WILMINGTON, Del. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Incyte Corporation (NASDAQ:INCY) and Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) announced today that the companies have entered into a target discovery, research collaboration . . .
Boston
